Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-209307

Chief Scientific Officer sold 8,000 shares at an average $14.62 ($116,996)

  • Chief Scientific Officer acquired 4,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Michaelson Jennifer · Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-05 Exercise or conversion : show line 1 in the form 10b5-1 +4,000 $4.30 $17,200 174,844 D
2026-05-05 Sale : show line 2 in the form 10b5-1 −7,800 $14.60 $113,880 167,044 D
2026-05-05 Sale : show line 3 in the form 10b5-1 −200 $15.58 $3,116 166,844 D
Open-market sales · 8,000 sh · avg $14.62 · $116,996

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-05 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) −4,000 116,987 D
Loading xslF345X06/ownership.xml…